Logo

Warnex to Distribute Gendia's Tests in Canada

Oct 08, 2008
NEW YORK (GenomeWeb News) – Quebec-based bioanalytical company Warnex said today that it has agreed to become the exclusive distributor of molecular diagnostic tests for the Gendia network in Canada.
 
Gendia is an international lab testing network with over 50 labs in the US, Europe, and Australia, and it offers more than 2,000 different genetic tests. Its goal is to provide and improve access, cost effectiveness, and quality for diagnostic tests for rare genetic disorders.
 
Warnex CEO Mark Busgang said in a statement that the agreement will help “provide access to a vast portfolio of highly specialized genetic tests ... that are not readily available in Canada.”

Breaking News
The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.